Area of research
Oncology · Cancer Research
Research interest
Research interests include Cancer research, Medicine, Lung cancer, Antibody, Biology, and Oncology.
RNase1-driven ALK-activation is an oncogenic driver and therapeutic target in non-small cell lung cancer
Nanoengineered hydrogels disrupt tumor antioxidant defense via photothermal-chemodynamic synergy and oxidative stress boosts
Targeting cancer stem-like cells via cholesterol modulation and ferroptosis induction using a multifunctional nanoplatform to overcome drug resistance
VHL suppresses autophagy and tumor growth through PHD1-dependent Beclin1 hydroxylation
A phase I/II, open-label, multicenter study to evaluate the safety, pharmacokinetics, pharmacodynamics, and efficacy of HB0036 in patients with advanced solid tumors.
Clinical Manifestation, Risk Factors, and Immune Checkpoint Inhibitor Rechallenge of Checkpoint Inhibitor–Associated Pneumonitis in Patients With Lung Cancer
Exosomes-regulated lipid metabolism in tumorigenesis and cancer progression
Chinese expert consensus on the diagnosis and treatment of thymic epithelial tumors
FN1 mediated activation of aspartate metabolism promotes the progression of triple-negative and luminal a breast cancer
Nucleus-exported CLOCK acetylates PRPS to promote de novo nucleotide synthesis and liver tumour growth
Chinese expert consensus on the diagnosis and treatment of malignant pleural mesothelioma
Correction: FN1-mediated activation of aspartate metabolism promotes the progression of triple-negative and luminal a breast cancer
Combining Immune-Related Genes For Delineating the Extracellular Matrix and Predicting Hormone Therapy and Neoadjuvant Chemotherapy Benefits In Breast Cancer
MiR-210 in exosomes derived from CAFs promotes non-small cell lung cancer migration and invasion through PTEN/PI3K/AKT pathway
SASH1 suppresses triple-negative breast cancer cell invasion through YAP-ARHGAP42-actin axis
MicroRNA-590-3p inhibits invasion and metastasis in triple-negative breast cancer by targeting Slug.
PubMed 2020cited by 29position: middle
Removal of N-Linked Glycosylation Enhances PD-L1 Detection and Predicts Anti-PD-1/PD-L1 Therapeutic Efficacy
Influence of disease uncertainty to emotion among advanced lung cancer chemotherapy patients
MCM2 is a therapeutic target of lovastatin in human non-small cell lung carcinomas
miR-211 promotes non-small cell lung cancer proliferation by targeting SRCIN1
Study of circulating IgG antibodies to BIRC5 and MYC in non‐small cell lung cancer
Circulating autoantibody to FOXP3 may be a potential biomarker for esophageal squamous cell carcinoma
Autoantibodies against p16 protein-derived peptides may be a potential biomarker for non-small cell lung cancer
Circulating IgG antibody against FOXP3 may be a potential biomarker for lung cancer
Immunopontentiating and antitumor activities of a polysaccharide from Pulsatilla chinensis (Bunge) Regel